Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v5-EN
Language English English
Date Updated 2022-06-11 2022-06-10
Drug Identification Number 00646024 00646024
Brand name HYDROXYZINE HYDROXYZINE
Common or Proper name Hydroxyzine CAP Hydroxyzine CAP
Company Name AA PHARMA INC AA PHARMA INC
Ingredients HYDROXYZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE
Strength(s) 25MG 25MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100BTL 100BTL
ATC code N05BB N05BB
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-05-03 2022-05-03
Actual start date
Estimated end date 2022-06-28 2022-06-28
Actual end date 2022-06-10 2022-06-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments